Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?
Aysel Kiyici, Idris Mehmetoğlu, Hatice Karaoğlan, Hüseyin Atalay, Yalçin Solak, Süleyman Türk
Index: J. Clin. Lab Anal. 24 , 273-277, (2010)
Full Text: HTML
Abstract
Ischemia-Modified albumin (IMA) has been used as an early marker in the evaluation of the patients with acute coronary syndrome. We aimed to evaluate IMA in end-stage renal disease (ESRD) patients on hemodialysis and the effect of albumin methods on albumin-adjusted IMA levels. A total of 30 ESRD patients were included in this study. Serum IMA and albumin levels were measured before and after a hemodialysis session. Albumin concentrations were determined with bromocresol green and bromocresol purple methods. Postdialysis IMA and albumin-adjusted IMA levels with two different albumin methods were significantly increased compared with the predialysis levels (P<0.05). However, we did not find any difference in albumin-adjusted IMA levels in either at the beginning or at the end of the dialysis session. IMA levels increase after hemodialysis, whereas albumin method has no effect on albumin-adjusted IMA levels.
Related Compounds
Related Articles:
2015-01-01
[BMC Complement Altern. Med. 15 , 244, (2015)]
2015-11-01
[Mol. Med. Report. 12 , 7657-64, (2015)]
2015-08-30
[J. Sci. Food Agric. 95 , 2222-7, (2015)]
2015-09-01
[Biol. Trace Elem. Res. 167 , 130-45, (2015)]
2015-09-01
[Anal. Bioanal. Chem 407 , 7037-46, (2015)]